These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


320 related items for PubMed ID: 11682952

  • 1. Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb; 78(2):84-9. PubMed ID: 11682952
    [Abstract] [Full Text] [Related]

  • 2. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [Abstract] [Full Text] [Related]

  • 3. Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes.
    Tonui WK, Ngumbi PM, Mpoke SS, Orago AS, Mbati PA, Turco SJ, Mkoji GM.
    East Afr Med J; 2004 Feb; 81(2):97-103. PubMed ID: 15125094
    [Abstract] [Full Text] [Related]

  • 4. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
    Anjili C, Langat B, Ngumbi P, Mbati PA, Githure J, Tonui WK.
    East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of Phlebotomus guggisbergi with Leishmania major and Leishmania tropica in a complex transmission setting for cutaneous leishmaniasis in Gilgil, Nakuru county, Kenya.
    Owino BO, Matoke-Muhia D, Alraey Y, Mwangi JM, Ingonga JM, Ngumbi PM, Casas-Sanchez A, Acosta-Serrano A, Masiga DK.
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007712. PubMed ID: 31626654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Laboratory demonstration of the acquisition and development of leishmania major in the sand fly Phlebotomus kazeruni (Diptera: Psychodidae).
    Hanafi HA, Fryauff DJ, Dykstra EA, Szumlas DE.
    J Egypt Soc Parasitol; 2007 Apr; 37(1):227-41. PubMed ID: 17580580
    [Abstract] [Full Text] [Related]

  • 12. [Protective effects of leishmanial antigens against Leishmania infantum infection in Lagurus lagurus].
    Chai J, Chang KP, Zuo X, Yan L, Hou Y, Zhang S, Ruziguli, Jiang W, Zhang L.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999 Apr; 17(4):237-40. PubMed ID: 12563775
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leishmania major infections in Phlebotomus duboscqi fed on murine models immunized with L. major subcellular antigens and sandfly gut antigens.
    Mbati PA, Anjili CO, Odongo S, Ogaja P, Tonui W.
    Onderstepoort J Vet Res; 2000 Mar; 67(1):57-63. PubMed ID: 10843323
    [Abstract] [Full Text] [Related]

  • 15. Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.
    Dobson DE, Kamhawi S, Lawyer P, Turco SJ, Beverley SM, Sacks DL.
    PLoS Pathog; 2010 Nov 11; 6(11):e1001185. PubMed ID: 21085609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.
    Firouzmand H, Sahranavard M, Badiee A, Khamesipour A, Alavizadeh SH, Samiei A, Soroush D, Tavassoti Kheiri M, Mahboudi F, Jaafari MR.
    Immunopharmacol Immunotoxicol; 2018 Feb 11; 40(1):72-82. PubMed ID: 29210292
    [Abstract] [Full Text] [Related]

  • 18. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
    Gomes R, Teixeira C, Oliveira F, Lawyer PG, Elnaiem DE, Meneses C, Goto Y, Bhatia A, Howard RF, Reed SG, Valenzuela JG, Kamhawi S.
    PLoS Negl Trop Dis; 2012 Feb 11; 6(4):e1610. PubMed ID: 22509423
    [Abstract] [Full Text] [Related]

  • 19. Expression of LPG and GP63 by different developmental stages of Leishmania major in the sandfly Phlebotomus papatasi.
    Davies CR, Cooper AM, Peacock C, Lane RP, Blackwell JM.
    Parasitology; 1990 Dec 11; 101 Pt 3():337-43. PubMed ID: 2092290
    [Abstract] [Full Text] [Related]

  • 20. Transmission and scanning EM-immunogold labeling of Leishmania major lipophosphoglycan in the sandfly Phlebotomus papatasi.
    Lang T, Warburg A, Sacks DL, Croft SL, Lane RP, Blackwell JM.
    Eur J Cell Biol; 1991 Aug 11; 55(2):362-72. PubMed ID: 1935998
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.